Article Data

  • Views 287
  • Dowloads 129

Original Research

Open Access

Conversion of laparoscopy to laparotomy due to adenxal malignancy

  • G. Biran1
  • A. Golan1
  • R. Sagiv1
  • M. Glezerman1
  • J. Menczer1,*,

1Department of Obstetrics and Gynecology and Gynecology Oncology Unit, Edith Wolfson Medical Center, Holon, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

DOI: 10.12892/ejgo200202157 Vol.23,Issue 2,March 2002 pp.157-160

Published: 10 March 2002

*Corresponding Author(s): J. Menczer E-mail:

Abstract

Purpose: The purpose of the present report was to assess the conversion rate from laparoscopy to laparotomy due to adnexal malignancy and to identify factors that might assist in the selection of the appropriate operative approach in patients with suspicious adnexal masses.

Methods: A retrospective review of the medical records of women who underwent laparoscopy due to ultrasonically complex adnexal masses. Ninety-five consecutive patients fulfilling these criteria, were identified. A comparison of patients with benign tumors who had laparoscopy only to those with invasive malignancies in whom laparoscopy was converted to laparotomy was performed.

Results: Malignancy was diagnosed in 18 (18.9%) patients. In 13 patients with malignancy (two borderline and 11 invasive), comprising 72.2% of the malignancies and 13.7% of the total group with complex adnexal masses, the laparoscopy was converted to laparotomy. Age of more than 50 years and a serum CA125 level above 35 U/ml were significantly more common in the malignant than in the benign group (90.9% vs. 15.6% and 63.6% vs. 11.6%, respectively; p < 0.0001 and p < 0.003, respectively). When both factors were present, the sensitivity and specificity for malignancy were 73.3% and 93.2%, respectively, and the positive and negative predictive values 73.3% and 95.6%, respectively.

Conclusion: When an ultrasonically complex adnexal mass is encountered, predictive factors for malignancy should be taken into account before the mode of intervention is chosen. The conversion from laparoscopy to laparotomy because of an invasive malignant tumor is acceptable, if it is performed immediately and a gynecologic oncologist is on stand-by.

Keywords

Laparoscopy; Conversion to laparotomy; Complex adnexal masses, Adnexal malignancy

Cite and Share

G. Biran,A. Golan,R. Sagiv,M. Glezerman,J. Menczer. Conversion of laparoscopy to laparotomy due to adenxal malignancy. European Journal of Gynaecological Oncology. 2002. 23(2);157-160.

References

[1] Pittaway D. E., Takacs P., Bauguess P.: "Laparoscopic adnexectomy: a comparison with laparotomy". Am. J. Ohstet. Gynecol., 1994, 171, 385.

[2] Hidlebaugh D. A., Vulgaropulos S., Orr R. K.:'Treating adnexal masses. Operative laparoscopy vs. laparotomy". J. Reprod. Med., 1997, 42, 551.

[3] Kadar N.: "Laparoscopic management of gynecologic mahgnancies". Curr. Opin. Obstet. Gynecol., 1997, 9, 247.

[4] CanisM .,Pouly J. L., WattiezA.,M age G.,M anhesH., Bruhat M A.: "Laparoscopic management of adnexal masses suspicious at ultrasound". Obstet. Gynecol., 1997, 89, 679.

[5] Childers J. M., Nasseri A., Surwit E. A.: "Laparoscopic management of suspicious adnexal masses". Am. J. Ohstet. Gynecol., 1996., 175,1451.

[6] Magrina J. F.: "Laparoscopic surgery for gynecologic cancers". Clin. Ohstet. Gynecol., 2000, 43, 619.

[7] Koonings P. P.,C ampbell K,,M ishell D. R,, Grimes D. A.: "Relative frequency of primary ovarian neoplasms: A ten year review" Obstet. Gynecol., 1989., 74, 921.

[8] Nezhat F., Nezhat C., Welander C. E., Benigno B.: "Four ovanan cancers diagnosed during laparoscopic management of 1011 women with adnexal mass". Am. J. Obstet. Gynecol., 1992, 167, 790.

[9] Ulrich U., Paulus W., Schneider A., Keckstein J.: "Laparoscoptc surgery for complex ovarian masses". J. Am. Assoc. Gynecol. Laparosc., 2000, 7, 373.

[10] Childers J. M.:'The virtues and pitfalls of minimal invasive surgery for gynecological malignancies". Curr. Opin. Obstet. Gynecol., 1999, II, 51.

[11] Hopkins M. P.:'The myths of laparoscopic surgery". Am. J. Obstet. Gynecol., 2000, 183, 1.

[12] Maiman M., Seltzer V., Boys J.: "Laparoscopic excision of ovarian neoplasm subsequently found to be malignant". Ohstet. Gynecol., 1991, 77, 563.

[13] Sevelda P., Dittrich C., Sazer H.: "'Prognostic value of the rupture of the capsule in stage I epithelial ovarian cancer". Gynecol Oncol., 1989, 35, 321.

[14] Dembo A. J,, Davy M., Stenwig A. E., Berll E. J., Bush R. S., Kjorstad K.: "Prognostic factors in in patients with stage I ovarian carcinoma". Obstet. Gynecol., 1990, 75, 263.

[15] Childers J.M.,A qua K. A., Surwit E. A.,H allum A. V.,H atch K D.: "Abdominal-wall tumor implantation after laparoscopy for malignant conditions". Obstet. Gynecol .,1994, 84, 765.

[16] Gleeson N. C., Nicosia S. V., Mark J. E.,H offman M. S., Cavanagh D.: "Abdominal wall metastases from ovarian cancer after laparoscopic removal". Am. J. Obstet. Gynecol., 1993, 169, 522.

[17] Wang P.H., Yuan C. C., Lin G., Ng H. T., Chao H. T.: "Risk factors contributing to early occurrence of port site metastases of laparoscopic surgery for malignancy". Gynecol. Oncol., 1999, 72, 38.

[18] Hopkins M. P., von Gruenigen V., Gaich S.: "Laparascopic port site implantation with ovarian cancer". Am. J. Obstet. Gynecol., 2000, 182, 735.

[19] Van Dam P.A.,D eCoedt J.,T jalma W. A. A.,B uytaert P.,B ecquart D., Vergote I. B.: "Trocar implantation metastases after laparoscopy in patients with advanced ovarian cancer: can the risk be reduced?". Am. J. Obstet. Gynecol., 1999, 181, 536.

[20] Kruitwagen R. F. P., Swinkels B. M., Keyser K. G. G., Doesburg W. H., Schijf Ch. P. Th.: "Incidence and effect on survival of abdominal wall metastases at trocar or puncture sites following laparoscopy or paracentesis in women with ovarian cancer". Gynecol. Oncol., 1996, 60, 233.

[21] Lehner R., Wenzl R., Heinz] H., Husslein P., Sevelda P.: "Influence of delayed staging laparotomy after laparoscopic removal of ovarian masses later found to be malignant". Obstet. Gynecol., 1998, 92, 967.

[22] Kindermann G., Maassen V., Kuhn W.: "Laparoscopic management of ovarian tumors subsequently diagnosed as malignant". J. Pelv. Surg., 1996, 2, 245.

[23] Rulin M. C., Preston A. L.: "Adnexal masses in postmenopausal women". Obstet. Gynecol., 1987, 79, 578.

[24] Ovadia F., Godman G. A.: "Ovarian masses in postmenopausal women". Int. J. Obstet. Gynecol., 1992, 39, 35.

[25] Jacobs I. et al.: "A risk of malignancy index incorporating CAl 25, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer". Br. J. Obstet. Gynecol., 1990, 97, 922.

[26] Van Nagell J. R., Deland F.: "Ultrasound evaluation of pelvic masses: predictors of malignancy for the general gynecologist". Curr. Opin. Obstet. Gynecol., 1999, II, 45.

[27] Hulka J. F., Parker W. H., Surrey M. W., Phillips J. M.: "Management of ovarian masses AAGL 1990 survey". J. Reprod. Med., 1992, 37, 599.

[28] Zaneta G., Lissoni A., Cha S. et al.: "Pre-operative morphology and color doppler features of borderline ovarian tumors". Br. J. Obstet. Gynecol., 1995, 102, 990.

[29] Burger C. V., Prinssen H. M., Baak J. P. A., Wagenaar N., Kenemans P.: "The management of borderline epithelial tumors of the ovary". Int. J. Gynecol. Cancer., 2000, 10, 181.

[30] Darai E., Teboul J., Fauconnier A., Scoazec J. Y., Benifla J. L., Madelenat P.: "Management and outcome of borderline ovarian tumors incidentally discovered at or after laparoscopy". Acta Obstet. Gynecol. Scand., 1998, 77, 451.

[31] Hsiu J. G., Given F. T., Kemp G. M.: "T\J mor implantation after diagnostic laparoscopic biopsy of serous ovarian tumors of low malignant potential". Obstet. Gynecol., 1986, 68, 90S.

[32] Shepherd J., Carter P. G., Lowe D. G.: "Wound recurrence by implantation of a borderline ovarian tumor following laparoscopic removal". Br. J. Obstet. Gynaecol., 1994, 101, 265.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top